Ribavirin 200 mg Tablets Under Non-Fasting Conditions

NCT00835536 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Ribavirin 200 mg tablets
DRUG: COPEGUS™ 200 mg Tablets

Sponsor

Teva Pharmaceuticals USA